Drug Type Small molecule drug |
Synonyms HS 336, HS-336, HS336 |
Target |
Action inhibitors |
Mechanism SHP2 inhibitors(Src homology phosphotyrosyl phosphatase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | IND Approval | China | 26 May 2023 | |
Esophageal Squamous Cell Carcinoma | IND Approval | China | 26 May 2023 | |
Non-Small Cell Lung Cancer | IND Approval | China | 26 May 2023 | |
Squamous Cell Carcinoma of Head and Neck | IND Approval | China | 26 May 2023 |